193 related articles for article (PubMed ID: 16396517)
1. Effects of transdermal estrogen replacement therapy on cardiovascular risk factors.
Menon DV; Vongpatanasin W
Treat Endocrinol; 2006; 5(1):37-51. PubMed ID: 16396517
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women.
Vongpatanasin W; Tuncel M; Wang Z; Arbique D; Mehrad B; Jialal I
J Am Coll Cardiol; 2003 Apr; 41(8):1358-63. PubMed ID: 12706932
[TBL] [Abstract][Full Text] [Related]
3. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
Weissberger AJ; Ho KK; Lazarus L
J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
[TBL] [Abstract][Full Text] [Related]
4. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.
Balfour JA; Heel RC
Drugs; 1990 Oct; 40(4):561-82. PubMed ID: 2083514
[TBL] [Abstract][Full Text] [Related]
5. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
Speroff L
Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
[TBL] [Abstract][Full Text] [Related]
6. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P
Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204
[TBL] [Abstract][Full Text] [Related]
7. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
8. KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women.
Abbas A; Fadel PJ; Wang Z; Arbique D; Jialal I; Vongpatanasin W
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):e164-7. PubMed ID: 15284085
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
[TBL] [Abstract][Full Text] [Related]
11. Are all estrogens created equal? A review of oral vs. transdermal therapy.
Goodman MP
J Womens Health (Larchmt); 2012 Feb; 21(2):161-9. PubMed ID: 22011208
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
[TBL] [Abstract][Full Text] [Related]
13. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
LaRosa JC
Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
[TBL] [Abstract][Full Text] [Related]
14. The menopause and hormone replacement therapy: lipids, lipoproteins, coagulation and fibrinolytic factors.
Tikkanen MJ
Maturitas; 1996 Mar; 23(2):209-16. PubMed ID: 8735358
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of atherosclerosis in postmenopausal women: alteration of atherosclerosis-associated factors and vascular atherosclerosis by oral and transdermal estrogen replacement].
Sumino H; Murakami M
Rinsho Byori; 2013 Mar; 61(3):256-62. PubMed ID: 23785796
[TBL] [Abstract][Full Text] [Related]
16. Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women.
Van Erpecum KJ; Van Berge Henegouwen GP; Verschoor L; Stoelwinder B; Willekens FL
Gastroenterology; 1991 Feb; 100(2):482-8. PubMed ID: 1898652
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Transdermal Estrogen Patch Use on Cardiovascular Outcomes: A Systematic Review.
Bezwada P; Shaikh A; Misra D
J Womens Health (Larchmt); 2017 Dec; 26(12):1319-1325. PubMed ID: 28622476
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
O'Sullivan AJ; Ho KK
J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
[TBL] [Abstract][Full Text] [Related]
19. Transdermal estradiol and lipid profile: effects on a specific group of Brazilian postmenopausal women.
Callejon DR; Rios DR; Franceschini SA; Toloi MR
Arq Bras Cardiol; 2009 Dec; 93(6):571-5, 617-22. PubMed ID: 20379635
[TBL] [Abstract][Full Text] [Related]
20. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
